Rehabilitation for People With Advanced Cancer
Project 3 - Phase II, Preference Based, Randomized Controlled Trial of Group-Based, In Person Versus Virtual, Cancer Rehabilitation for People With Metastatic / Advanced Breast or Colorectal Cancers
1 other identifier
interventional
111
1 country
1
Brief Summary
The proposed study is a Phase II, feasibility, randomized controlled preference based study. This will be conducted in Vancouver and Toronto and includes breast and colorectal cancers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2022
CompletedFirst Posted
Study publicly available on registry
June 21, 2022
CompletedStudy Start
First participant enrolled
December 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 16, 2026
CompletedFebruary 25, 2026
February 1, 2026
2.7 years
April 13, 2022
February 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Drop-out rates as a measure of feasibility (demand/update of intervention)
Number of patients who complete the study/ drop-out will be used to identify feasibility of the intervention.
6 months
Patient preference as assessed during clinical support as a measure of feasibility (acceptability)
Check-ins with Kinesiologist during assessments will be used to identify intervention acceptability/preference.
6 months
Measuring safety/practicality as assessed during one-on-one with the health coach (analyzed as qualitative data)
Completed over MS Teams/in-person and will be a conversational question and answer format.
6 months
Secondary Outcomes (23)
Demographics
6 months
Disability
6 months
Physical functioning
6 months
Social functioning
6 months
Depression
6 months
- +18 more secondary outcomes
Other Outcomes (2)
Performance Status
6 months
Measure of performance status
6 months
Study Arms (3)
Standard best cancer practice
NO INTERVENTIONAll participants (intervention arms 1 and 2, and control) will receive usual oncology care by their health care providers which includes recommendations for general aerobic and resistance exercise. Participants in the control group will be of recommended to work towards the recommended 90 minutes moderate to vigorous aerobic exercise, and two days a week of large muscle group strength training as recommended by the ACSM. A general brochure will be provided to all control participants providing education in line with current standard of care. This safety precautions noted these will be indicated brochure will have an open text field on the back which will allow the kinesiologist to provide and general advice at each time point. If there are particular here. Participants in all study arms may also be referred by treating health care providers to usual supportive care or early palliative care services at any time deemed necessary, and will be recorded as part of monthly data collection.
In-person Intervention arm
EXPERIMENTALThe in-person intervention arm is an 8-week program and four week short maintenance period. This includes 1 hr of in-person, group-based exercise guided by a qualified exercise professional followed by 1 hr of in-person, group based, self-management education provided by a rehabilitation expert to occur immediately following the exercise session. Each participant is given a FitBit® to track steps, heart rate and sleep. Each site (i.e., Toronto and Vancouver) will run independent, in-person exercise and educational programs based on local referrals. Self management sessions include 8 high priority topics for advanced cancer patients including: 1) goal setting, 2) managing pain, 3) reducing fatigue and improving sleep, 4) boosting brain health, 5) eating and cooking for wellness, 6) managing emotions, 7) being mindful, and 8) planning for the future. Education sessions will be run by local experts at each site.
Virtual Intervention arm
EXPERIMENTALThe virtual intervention arm will be an 8-week program plus four week short maintenance period but will include two separate 1 hour sessions per week. This includes: 1) 60 minutes of virtual, group-based, synchronous exercise over a virtual secure platform; and, 2) A separate 60 min virtual synchronous education session provided on a separate day (to prevent virtual fatigue). 3) Encouragement to participate in a home program the other days of the week, striving for the recommended 90 min of moderate to vigorous aerobic exercise and 2 days of week or resistance exercise. The virtual intervention group will combine participants across both study locations and run sessions when sufficient numbers are recruited. Self-management education content will be unchanged to the in-person sessions but conducted over a virtual platform (i.e., videoconferencing) with participants also attending virtually.
Interventions
participants who have chosen to complete the study intervention by coming in for their 8 week education and exercise sessions.
Participants who have chosen to complete the study virtually instead of in-person sessions.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Diagnosed with locally advanced incurable or metastatic breast or colorectal cancer
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
- Fully independent with ambulation and transfers with or without ambulatory assistance
- Palliative Performance score of \>70 (moderate predictive power estimating life expectancy \>6 months)
- Receiving first or second line anti-cancer treatments in the metastatic / incurable setting (a relative proxy for expected survival \>6 months)
- Medical clearance to participate from treating physician
You may not qualify if:
- Wheelchair level community ambulation
- Moderate or severe non-cancer pain (\>6 out of 10 on visual analog scale)
- Moderate or severe cancer bone pain (\>Gr 2 bone pain (i.e., moderate pain limiting instrumental ALDs or worse) as measured on CTCAE (see below))
- Severe or uncontrolled depressive symptoms (\>20 on PHQ-9)
- Known neurological conditions influencing cognition and preventing safe or appropriate engagement with self-management and exercise recommendations (e.g., dementia, traumatic brain injury, or brain metastasis influencing cognition or causing moderate-to-severe motor-sensory-coordination). Best determined by the referring physician or nurse practitioner.
- Unable to communicate sufficiently in English to complete intervention, questionnaires, and consent.
- Unwillingness to be randomized, participate in a group intervention, or attend individual physical assessments.
- Inability to operate videoconferencing if preference is virtual programming.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Princess Margaret Cancer Centre
Toronto, Ontario, M5G2M9, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Jones, PhD
University Health Network, Toronto
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 13, 2022
First Posted
June 21, 2022
Study Start
December 2, 2022
Primary Completion
July 30, 2025
Study Completion
January 16, 2026
Last Updated
February 25, 2026
Record last verified: 2026-02